Using NLP feedback to enhance communication in prostate cancer consultations
Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men With Clinically Localized Prostate Cancer
This study is testing whether a new feedback system using technology can help improve communication during doctor visits for men who have just been diagnosed with prostate cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT05923684 on ClinicalTrials.gov |
What this trial studies
This pilot study aims to assess the feasibility of a natural language processing (NLP) feedback system in improving communication during consultations for men newly diagnosed with prostate cancer. The study will involve audio recording and transcribing treatment discussions, followed by the extraction of key content areas using NLP. Reports summarizing the most relevant information will be provided to both patients and physicians within two weeks of the consultation. Additionally, the study will evaluate changes in patients' decisional conflict and risk perception, as well as physicians' communication quality over time.
Who should consider this trial
Good fit: Ideal candidates are men undergoing initial treatment consultations for clinically localized prostate cancer.
Not a fit: Patients with advanced or metastatic prostate cancer or those who have already received treatment for localized prostate cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance patient understanding and decision-making in prostate cancer treatment.
How similar studies have performed: While NLP applications in healthcare are emerging, this specific approach to enhancing communication in prostate cancer consultations is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Men undergoing initial treatment consultation for clinically localized prostate cancer; 2. Men with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy. 3. Cedars-Sinai patient. 4. Ability to read and write in English. Exclusion Criteria: 1. Under 18 years of age; 2. Subjects with difficulty communicating or dementia; 3. Non-English speakers, given that our NLP-based tools cannot be used with languages other than English; 4. Men with locally advanced or metastatic prostate cancer; 5. Men who have already been treated for clinically localized prostate cancer
Where this trial is running
Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: Timothy Daskivich — Cedars-Sinai Medical Center
- Study coordinator: Timothy Daskivich, MD
- Email: timothy.daskivich@cshs.org
- Phone: 3104230415
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.